Morepen Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

25 Apr 2018 | 12:00 AM

38.25
-0.15 (-0.39%)

  • Outperforms Index

    84.78%

    Return (1Y)

    Beaten S&P BSE Healthcare by 92.96%

  • More Volatile

    3.9%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.84%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

44

44.35

15

14.80

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Morepen Laboratories Ltd has increased by 11400% since past 1 Year

Loading...